House of Lords Business
Show full summary

Lord Mendelsohn to ask His Majesty's Government, further to the Written Answer by Lord Kamall on 12 April 2022 (HL7711), what the findings of the OCTAVE-DUO work were on providing evidence of immune response following subsequent vaccine doses for the immunocompromised. 

Question HL5221: tabled on 30 January 2023 and due for answer by 13 February 2023

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Mendelsohn to ask His Majesty's Government, further to the Written Answer by Lord Kamall on 12 April 2022 (HL7711), what the findings of the OCTAVE-DUO work were on providing evidence of immune response following subsequent vaccine doses for the immunocompromised.  HL5221
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Date Answered

Wednesday 8 February 2023

Member's Registered Interests

There are no interests to show.

Main Member

Lord Mendelsohn
Labour
Life peer